| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |